Jill Blumenthal, MD, MAS, offers some insights on the results from a subset of Gilead’s phase 3 PURPOSE 2 study.
Jill Blumenthal, MD
Advertisement
Blumenthal is a professor in the Division of Infectious Diseases and Global Public Health in the Department of Medicine at UC San Diego Health.
Articles by Jill Blumenthal, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Rapid HCV Test Provides Opportunity for Single Visit Diagnosis and Treatment Encounters
2
Phage and Antibiotic Combination Therapy for Biofilm-Associated Bacterial Infections
3
No Negative Impact for Individuals Taking Lenacapavir and Gender-Affirming Hormone Therapy
4
Clinical Takeaways From ViiV’s PASO DOBLE and CLARITY Studies
5
